. "UPN4ITI8T4"^^ . "52128-35-5"^^ . "A methotrexate derivative with potential antineoplastic activity. Trimetrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylate, with subsequent inhibition of DNA and RNA synthesis. Trimetrexate also exhibits antiviral activity. (NCI04)NCI" . "TrimexateSYNCI" . "2,4-Quinazolinediamine, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-SYDTPNSC0249008" . . . . "C0085176"^^ . "249008"^^ . "C19H23N5O3"^^ . "Pharmacologic Substance"^^ . "TMQABNCI" . "CI-898CNNCI" . "A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against Pneumocystis carinii pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect.MSH2002_06_01" . "5-Methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-2,4-quinazolinediamineSNNCI" . "C1314"^^ . "TrimetrexateSYDTPNSC0352122" . "TRIMETREXATEPTFDAUPN4ITI8T4" . . "Trimetrexate"^^ . . . "Trimetrexate"^^ . "FDA"^^ . "Organic Chemical"^^ . "Trimetrexate"^^ . "TrimetrexatePTNCI" .